BCR-ABL1 F359I
|
CML
|
BCR-ABL1 F359I
|
CML
|
nilotinib Resistant: A2 - Guideline
|
nilotinib Resistant: A2 - Guideline
|
BCR-ABL1 F359I
|
ALL
|
BCR-ABL1 F359I
|
ALL
|
nilotinib Resistant: A2 - Guideline
|
nilotinib Resistant: A2 - Guideline
|
BCR-ABL1 F359I
|
CML
|
BCR-ABL1 F359I
|
CML
|
bosutinib Sensitive: C3 – Early Trials
|
bosutinib Sensitive: C3 – Early Trials
|